Cybin  GAAP EPS of -$1.00 misses by $0.41

* Cybin  press release [https://seekingalpha.com/pr/20399084-helus-pharma-reports-third-quarter-fiscal-year-2026-financial-results-and-recent-business] (HELP [https://seekingalpha.com/symbol/HELP]): Q3 GAAP EPS of -$1.00 misses by $0.41.

MORE ON CYBIN 

* Cybin 2026 Outlook: Clinical Milestones And Cash Position Set Stage For Momentum [https://seekingalpha.com/article/4856782-cybin-2026-outlook-clinical-milestones-and-cash-position-set-stage-for-momentum]
* Biggest stock movers Wednesday: Vanda Pharmaceuticals, Axsome Therapeutics and Cybin [https://seekingalpha.com/news/4535967-biggest-stock-movers-wednesday-vanda-pharmaceuticals-and-cybin]
* Psychedelics stocks could benefit from marijuana rescheduling: Jefferies [https://seekingalpha.com/news/4533557-psychedelics-stock-could-benefit-marijuana-rescheduling-jefferies]
* Seeking Alpha’s Quant Rating on Cybin  [https://seekingalpha.com/symbol/HELP/ratings/quant-ratings]
* Historical earnings data for Cybin  [https://seekingalpha.com/symbol/HELP/earnings]